Risk/benefit of BTK/venetoclax combos: the context matters!

Blood. 2024 Feb 15;143(7):563-564. doi: 10.1182/blood.2023022896.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Adenine / analogs & derivatives*
  • Bridged Bicyclo Compounds, Heterocyclic
  • Humans
  • Piperidines*
  • Protein-Tyrosine Kinases
  • Sulfonamides
  • Waldenstrom Macroglobulinemia*

Substances

  • venetoclax
  • ibrutinib
  • Sulfonamides
  • Protein-Tyrosine Kinases
  • Bridged Bicyclo Compounds, Heterocyclic
  • Adenine
  • Piperidines